| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,519 | 3,682.6000 | 3,618.8000 | 4,131.1000 | 1,470.5000 |
|
Cost of Revenue
|
-2,996.5000 | -1,675.2000 | -619 | -164.9000 | -54.5000 |
|
Gross Profit
|
1,522.5000 | 2,007.4000 | 2,999.8000 | 3,966.2000 | 1,416 |
| Selling, General and Administrative Expenses
|
-143,327 | -121,633.4000 | -137,000.5000 | -10,158.3000 | -10,971.5000 |
|
Research and Development Expenses
|
-33,776.3000 | -42,773.8000 | -49,104.3000 | -9,715.7000 | -13,633.1000 |
| Depreciation, Amortization and Depletion
|
-7,544.1000 | -7,421.3000 | -2,933.9000 | -59.6000 | -58.7000 |
|
Operating Income/Expenses
|
-184,647.4000 | -171,828.5000 | -189,038.7000 | -19,933.6000 | -24,663.3000 |
|
Total Operating Profit/Loss
|
-183,124.9000 | -169,821.1000 | -186,038.9000 | -15,967.4000 | -23,247.3000 |
| Total Net Finance Income/Expense
|
-10,128.4000 | 19,212.9000 | 11,632.4000 | -39,429.1000 | -2,038.7000 |
| Net Investment Income
|
-1,137,876.7000 | -586,178.6000 | -225,916 | -2,791.6000 | 75,809.9000 |
| Irregular Income/Expenses
|
26,970.6000 | 25,006.7000 | 0 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
0 | 0 | -542.3000 | 0 | 0 |
|
Non-Operating Income/Expenses, Total
|
-1,121,034.5000 | -541,959 | -214,825.9000 | -42,220.7000 | 73,771.2000 |
|
Pretax Income
|
-1,304,159.4000 | -711,780.1000 | -400,864.8000 | -58,188.1000 | 50,523.9000 |
|
Provision for Income Tax
|
-447.5000 | -560.1000 | 0 | -1.1000 | -0.2000 |
|
Net Income from Continuing Operations
|
-1,304,606.9000 | -712,340.2000 | -400,864.8000 | -58,189.2000 | 50,523.7000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,304,606.9000 | -712,340.2000 | -400,864.8000 | -58,189.2000 | 50,523.7000 |
|
Non-Controlling/Minority Interests
|
404.9000 | 278.8000 | 0 | 0 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-1,304,202 | -712,061.4000 | -400,864.8000 | -58,189.2000 | 50,523.7000 |
|
Net Income Available to Common Stockholders
|
-1,304,202 | -712,061.4000 | -400,864.8000 | -58,189.2000 | 50,523.7000 |
|
Diluted Net Income Available to Common Stockholders
|
-1,304,202 | -712,061.4000 | -400,864.8000 | -58,189.2000 | 50,523.7000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,294,031 | -730,993 | -412,497.2000 | -18,759 | 52,562.6000 |
|
EBITDA
|
-1,285,514.9000 | -722,660.9000 | -409,144.4000 | -18,544.8000 | 52,708.5000 |
|
Normalized EBITDA
|
-29,090.1000 | -24,879.7000 | -22,345.6000 | -7,030.2000 | -23,188.6000 |
|
Normalized Income
|
-672,604.7670 | 96,689.7940 | -67,019.4000 | -55,983.8360 | -25,285.8968 |
|
Total Unusual Items
|
800,002.7000 | 1,024,088.6000 | 333,845.4000 | 2,791.6000 | -75,809.9000 |
|
Total Unusual Items Excluding Goodwill
|
800,002.7000 | 1,024,088.6000 | 333,845.4000 | 2,791.6000 | -75,809.9000 |
|
Tax Effect of Unusual Items
|
168,000.5670 | 215,058.6060 | 0 | 586.2360 | -0.3032 |
|
Tax Rate, Calculated
|
0.21 | 0.21 | 0.00 | 0.21 | 0.00 |
12/31/2022 - 7/17/2026
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade